EcoDrugPlus

Somatostatin Receptor 5

Ensembl ID : ENSXMAG00000022583
Gene Symbol: SSTR5
3 Cross references
188 Possible Orthologues:

Somatostatin Receptor Type 5-Like

Ensembl ID : ENSXMAG00000023809
Gene Symbol: LOC102220725
2 Cross references
183 Possible Orthologues:

Sphingosine Kinase 2

Ensembl ID : ENSXMAG00000022906
Gene Symbol: SPHK2
2 Cross references
200 Possible Orthologues:

Sphingosine-1-Phosphate Receptor 1

Ensembl ID : ENSXMAG00000019798
Gene Symbol: S1PR1
3 Cross references
200 Possible Orthologues:

Spleen Associated Tyrosine Kinase

Ensembl ID : ENSXMAG00000027600
Gene Symbol: SYK
3 Cross references
199 Possible Orthologues:

Steroid 17-Alpha-Hydroxylase/17,20 Lyase

Ensembl ID : ENSXMAG00000005813
Gene Symbol: LOC102238057
3 Cross references
210 Possible Orthologues:

Steroid 5 Alpha-Reductase 2

Ensembl ID : ENSXMAG00000006388
Gene Symbol: SRD5A2
3 Cross references
191 Possible Orthologues:

Sterol O-Acyltransferase 1

Ensembl ID : ENSXMAG00000003187
Gene Symbol: SOAT1
3 Cross references
210 Possible Orthologues:

Substance-P Receptor-Like

Ensembl ID : ENSXMAG00000025133
Gene Symbol: LOC102223307
3 Cross references
193 Possible Orthologues:

Synuclein Alpha

Ensembl ID : ENSXMAG00000024787
Gene Symbol: SNCA
4 Cross references
189 Possible Orthologues:

Tachykinin Receptor 1

Ensembl ID : ENSXMAG00000010211
Gene Symbol: TACR1
4 Cross references
194 Possible Orthologues:

Tachykinin Receptor 2

Ensembl ID : ENSXMAG00000014703
Gene Symbol: TACR2
3 Cross references
196 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).